|Form of Medicine||Capsule|
|Quantity Per Pack||1*30|
|No of tablets||30|
Generic Content- Ceritinib, Manufactured By: Natco,India
Ceritinib is a prescription-only drug used for the treatment non-small cell lung cancer. It was developed by Novartis and received FDA approval for use in April 2014. It is available as a 150 mg capsule with a one-time daily dosing requirement of 750 mg for NSCLC.
|Packaging Type||3 Bottles|
|Storage Condition||room temprature|
|No of tablets||150|